Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$1.25B |
| 2 |
Home Depot
HD
|
+$645M |
| 3 |
Gilead Sciences
GILD
|
+$621M |
| 4 |
Navient
NAVI
|
+$609M |
| 5 |
Exelon
EXC
|
+$583M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P Retail ETF
XRT
|
+$1.17B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$611M |
| 3 |
SLM Corp
SLM
|
+$564M |
| 4 |
CIE
Cobalt International Energy, Inc
CIE
|
+$403M |
| 5 |
DuPont de Nemours
DD
|
+$379M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 8.18% |
| 2 | Financials | 7.69% |
| 3 | Technology | 7.67% |
| 4 | Healthcare | 6.64% |
| 5 | Industrials | 5.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FRAN
5501
DELISTED
Francesca's Holdings Corporation
FRAN
| $366K | ﹤0.01% |
2,068
+2
| +0.1% | +$386 |
|
|
RDEN
5502
CALL
DELISTED
ELIZABETH ARDEN INC
RDEN
| $366K | ﹤0.01% |
+17,100
| New | +$492K |
|
5503
Medifast
MED
$107M
| $365K | ﹤0.01% |
12,008
-21,174
| -64% | -$660K |
|
|
ARRY
5504
CALL
DELISTED
Array Biopharma Inc
ARRY
| $365K | ﹤0.01% |
+80,000
| New | +$331K |
|
|
ARRY
5505
PUT
DELISTED
Array Biopharma Inc
ARRY
| $365K | ﹤0.01% |
+80,000
| New | +$331K |
|
|
CVRR
5506
CALL
DELISTED
CVR Refining, LP
CVRR
| $365K | ﹤0.01% |
14,600
-1,800
| -11% | -$46K |
|
5507
PUT
Century Aluminum
CENX
$4.22B
| $364K | ﹤0.01% |
23,200
-19,700
| -46% | -$279K |
|
5508
ProShares UltraShort FTSE Europe
EPV
$11.6M
| $364K | ﹤0.01% |
1,392
| – | – |
|
5509
PUT
Open Text
OTEX
$6.28B
| $364K | ﹤0.01% |
15,200
+13,600
| +850% | +$322K |
|
5510
ProShares UltraShort Financials
SKF
$10.3M
| $364K | ﹤0.01% |
367
-2,086
| -85% | -$2.19M |
|
|
CFN
5511
CALL
DELISTED
CAREFUSION CORPORATION
CFN
| $364K | ﹤0.01% |
8,200
-191,800
| -96% | -$7.94M |
|
5512
ProShares UltraShort Euro
EUO
$35.2M
| $363K | ﹤0.01% |
21,263
-68,268
| -76% | -$1.16M |
|
5513
PUT
Leidos
LDOS
$14.4B
| $363K | ﹤0.01% |
9,475
-2,625
| -22% | -$99.4K |
|
5514
PUT
SM Energy
SM
$7.6B
| $362K | ﹤0.01% |
4,300
+1,600
| +59% | +$123K |
|
|
AAV
5515
DELISTED
Advantage Oil & Gas Ltd
AAV
| $362K | ﹤0.01% |
53,873
-4,367
| -7% | -$26.6K |
|
|
BID
5516
CALL
DELISTED
Sotheby's
BID
| $361K | ﹤0.01% |
8,600
-137,900
| -94% | -$5.61M |
|
|
CVSA
5517
CALL
Covista Inc
CVSA
$4.55B
| $360K | ﹤0.01% |
8,500
+1,000
| +13% | +$42.5K |
|
5518
CALL
Broadcom
AVGO
$1.76T
| $360K | ﹤0.01% |
50,000
| – | – |
|
|
CIVI
5519
CALL
DELISTED
Civitas Resources
CIVI
| $360K | ﹤0.01% |
+56
| New | +$317K |
|
5520
CALL
Diana Shipping
DSX
$266M
| $360K | ﹤0.01% |
47,344
-343,564
| -88% | -$2.74M |
|
5521
CALL
Leggett & Platt
LEG
$1.4B
| $360K | ﹤0.01% |
10,500
+400
| +4% | +$13.3K |
|
|
TSC
5522
DELISTED
TriState Capital Holdings, Inc.
TSC
| $360K | ﹤0.01% |
+25,467
| New | +$348K |
|
|
GSOL
5523
DELISTED
Global Sources Ltd
GSOL
| $360K | ﹤0.01% |
43,439
+31,077
| +251% | +$261K |
|
5524
Angi Inc
ANGI
$247M
| $359K | ﹤0.01% |
3,003
-5,126
| -63% | -$585K |
|
|
APAGF
5525
DELISTED
APCO OIL AND GAS INTERNATIONAL INC
APAGF
| $359K | ﹤0.01% |
24,890
-4,698
| -16% | -$67.8K |
|
Similar funds
Goldman Sachs's Q2 2014 Portfolio in Review
As of Q2 2014, Goldman Sachs held 7,392 positions worth $319B, up 4.4% from $306B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Goldman Sachs's Q2 2014 filing shows 646 new, 2,991 increased, 3,008 reduced and 432 closed positions. Its largest new stake was Navient: 36,826,072 shares worth $652M. The largest sale was State Street SPDR S&P Retail ETF, an estimated $1.17B.
By sector, the portfolio is most concentrated in Energy at 8.2% of assets, up from 7.4% a quarter earlier, followed by Financials and Technology.
- Goldman Sachs's largest Q2 2014 buy was Navient: 36,826,072 shares worth $652M.
- Goldman Sachs added most to iShares Russell 2000 ETF in Q2 2014, an estimated $1.25B increase.
- Goldman Sachs's biggest Q2 2014 reduction was State Street SPDR S&P Retail ETF, cutting an estimated $1.17B.
- Goldman Sachs fully exited CHINA NEPSTAR CHAIN DRUGSTORE LTD. COM in Q2 2014, selling an estimated $59.8M.
- Goldman Sachs's ten largest holdings make up 13% of its $319B portfolio in Q2 2014.
- Goldman Sachs opened 646 new positions and closed 432 in Q2 2014.
- Goldman Sachs's portfolio value rose 4.4% quarter-over-quarter to $319B.
Based on Goldman Sachs's 13F filing for Q2 2014, filed 14 Aug 2014.